Our source library

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.

1. CoreAge Rx: current advertised treatments and pricesProvider starting prices; final plan and billing terms require confirmation
2. CoreAge Rx Help Center: current product catalogProvider formulation and consultation information
3. Musely — anti-aging treatment catalogProvider product and advertised-price information
4. Musely — The Anti-Aging CreamProduct page; price expressed as a monthly equivalent for a two-month supply
5. Musely — The Aging Repair CreamProduct page; provider-reported outcomes are not independent comparative trials
6. Curology — personalized prescription skincareProvider overview and subscription offers
7. Curology — HydroTret Rx, formerly Future-Proof RxCurrent product name, ingredients and advertised prices
8. Curology — Custom Formula RxFormula options and consultation process
9. Curology — ingredient directoryProvider-maintained ingredient lists; updated September 23, 2026
10. American Academy of Dermatology — Retinoid or retinol?Dermatology guidance on retinoids, irritation and pregnancy
11. American Academy of Dermatology — How to select anti-aging skin care productsSunscreen, moisturizers, realistic expectations and label claims
12. FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations
13. Ro: weight-loss careProvider care model and current medication menu
14. Ro: membership and medication pricingSeparate charges, prepayment periods and dose-specific offers
15. Ro: Wegovy accessProvider access information, not independent clinical evidence
16. Ro: Zepbound accessProvider product access and care terms
17. Zepbound prescribing informationManufacturer prescribing information, warnings and approved uses
18. Wegovy prescribing informationManufacturer labeling; formulation-specific directions and safety information
19. FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags
20. FDA: ingredients suitable for sterile compoundingAgency reports about NAD+ injectable drugs; not a finding specific to CoreAge Rx
21. NIH ODS: exercise and athletic performance supplementsIngredient research, not an evaluation of Strong Suit
22. NIH ODS: probioticsStrain-specific evidence and supplement-label considerations
23. NIH ODS: dietary supplements, what you need to knowRegulation, interactions, quality and evidence
24. NIDDK: treatment for constipationGeneral digestive-care context, not evidence for a particular supplement